No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
AstraZeneca to Acquire Amolyt Pharma for $1.05B
On 14 March 2024, AstraZeneca announced that it has entered into an agreement to acquire Amolyt Pharma, a clinical-stage biotechnology company focused on developing novel treatments for rare endocrine diseases. Amoylt's portfolio notably includes eneboparatide...